Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic.
In: Scientific Reports, Jg. 12 (2022-07-28), Heft 1, S. 1-7
Online
academicJournal
Zugriff:
Early predictions forecasted large numbers of severe acute respiratory syndrome coronavirus (SARS-CoV-2) cases and associated deaths in Africa. To date, Africa has been relatively spared. Various hypotheses were postulated to explain the lower than anticipated impact on public health in Africa. However, the contribution of pre-existing immunity is yet to be investigated. In this study, the presence of antibodies against SARS-CoV-2 spike (S) and nucleocapsid (N) proteins in pre-pandemic samples from Africa, Europe, South and North America was examined by ELISA. The protective efficacy of N specific antibodies isolated from Central African donors was tested by in vitro neutralization and in a mouse model of SARS-CoV-2 infection. Antibodies against SARS-CoV-2 S and N proteins were rare in all populations except in Gabon and Senegal where N specific antibodies were prevalent. However, these antibodies failed to neutralize the virus either in vitro or in vivo. Overall, this study indicates that cross-reactive immunity against SARS-CoV-2 N protein was present in Africa prior to the pandemic. However, this pre-existing humoral immunity does not impact viral fitness in rodents suggesting that other human immune defense mechanisms could be involved. In Africa, seroprevalence studies using the N protein are over-estimating SARS-CoV-2 circulation. [ABSTRACT FROM AUTHOR]
Copyright of Scientific Reports is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic.
|
---|---|
Autor/in / Beteiligte Person: | Pedersen, Jannie ; Koumakpayi, Ismaël Hervé ; Babuadze, Giorgi ; Baz, Mariana ; Ndiaye, Oumar ; Faye, Oumar ; Diagne, Cheikh Tidiane ; Dia, Ndongo ; Naghibosadat, Maedeh ; McGeer, Allison ; Muberaka, Samira ; Moukandja, Irène P. ; Ndidi, Stella ; Tauil, Carlos B. ; Lekana-Douki, Jean-Bernard ; Loucoubar, Cheikh ; Faye, Ousmane ; Sall, Amadou ; Magalhães, Kelly G. ; Weis, Nina |
Link: | |
Zeitschrift: | Scientific Reports, Jg. 12 (2022-07-28), Heft 1, S. 1-7 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 2045-2322 (print) |
DOI: | 10.1038/s41598-022-17241-9 |
Schlagwort: |
|
Sonstiges: |
|